Hypotheses

In older human muscle, removing damaged material before copying its spatial pattern could impair ordered replacement and later force. Normal organized recovery after verified selective pattern erasure, with alternative cues intact, would weaken the proposed need for that information

Explains the gap: Does accelerating damaged-material clearance worsen human aging when replacement lags, and can reversing the clearance–replenishment order prevent cumulative reserve loss despite slower removal?

In aging human muscle, renewal may sever critical force-transmitting routes before replacement, causing lasting loss. A selective null in a preidentified vulnerable layout would weaken this mechanism; temporary force loss or bypass rescue alone would not establish it

Explains the gap: Does accelerating damaged-material clearance worsen human aging when replacement lags, and can reversing the clearance–replenishment order prevent cumulative reserve loss despite slower removal?

In aging human muscle, intact damaged old proteins could join newly forming contractile complexes and impair new material beyond ordinary mixture effects. A sensitive test showing no such impairment, with selective exclusion validated, would weaken the mechanism for the chosen protein.

Explains the gap: Does accelerating damaged-material clearance worsen human aging when replacement lags, and can reversing the clearance–replenishment order prevent cumulative reserve loss despite slower removal?

In older human muscle after a mild lesion, mismatched readiness windows in precursors and recipient fibers could impair fusion and force recovery. Normal competence and fusion plus an ineffective selective timing correction would weaken this explanation in that setting.

Explains the gap: Does accelerating damaged-material clearance worsen human aging when replacement lags, and can reversing the clearance–replenishment order prevent cumulative reserve loss despite slower removal?

In older-donor epithelial mosaics, fusion with resident cells may restore growth control in invasive descendants through retained resident alleles. Selective fusion or allele tests showing no effect, with adequate event detection, would limit this proposed protection in the tested setting.

Explains the gap: During human aging, can suppressing expanding epithelial clones accelerate dangerous invasion by removing protective competitors, and what distinguishes this ecological release from removal of genuinely dysfunctional lineages across repeated repair?

In older-donor epithelial mosaics, resident daughters may restrain invaders by replacing their renewing positions. Selectively changing and restoring replacement must predict invader growth in held-out repairs; failure would bound the mechanism or reject its proposed predictive reduction

Explains the gap: During human aging, can suppressing expanding epithelial clones accelerate dangerous invasion by removing protective competitors, and what distinguishes this ecological release from removal of genuinely dysfunctional lineages across repeated repair?

In older-donor intestinal epithelial mosaics, barrier loss may expose surviving renewing cells to microbial toxins that create invasion-causing mutations. Failure to show increased exposure, surviving new mutations or their causal role in invasion would bound this mechanism in the tested setting

Explains the gap: During human aging, can suppressing expanding epithelial clones accelerate dangerous invasion by removing protective competitors, and what distinguishes this ecological release from removal of genuinely dysfunctional lineages across repeated repair?

In older-donor epithelial mosaics, retained dead-cell material may fuel extra survival or growth of an existing invasive lineage. Verified selective interruption of its metabolic use without loss of that extra output would bound the feeding contribution, provided injury responses and alternative nutrition remain intact.

Explains the gap: During human aging, can suppressing expanding epithelial clones accelerate dangerous invasion by removing protective competitors, and what distinguishes this ecological release from removal of genuinely dysfunctional lineages across repeated repair?

In a subset of aging humans with postinfectious exertional intolerance, new muscle proteins may initially generate force but fail early because of amino-acid sequence errors. Adequately sensitive measurements excluding enough consequential errors to explain the later loss would weaken this mechanism locally

Explains the gap: Does rehabilitation that restores measured reserve nevertheless accelerate subsequent functional loss in aging humans with postinfectious exertional intolerance, contradicting the prediction that reversing deconditioning closes the recovery cycle?

In some aging humans with postinfectious exertional intolerance, a damaged connective-tissue path could spread failure despite early rehabilitation gains. Testing must demonstrate mechanical transmission; absent reproducible regions or a vulnerable path would weaken the proposal.

Explains the gap: Does rehabilitation that restores measured reserve nevertheless accelerate subsequent functional loss in aging humans with postinfectious exertional intolerance, contradicting the prediction that reversing deconditioning closes the recovery cycle?

In some aging humans with postinfectious exertional intolerance, contraction-released heme iron could sustain new lipid damage despite early reconditioning. Sensitive tests finding no preceding catalytic rise or no less injury after selective interruption would constrain this mechanism in the tested compartment and window.

Explains the gap: Does rehabilitation that restores measured reserve nevertheless accelerate subsequent functional loss in aging humans with postinfectious exertional intolerance, contradicting the prediction that reversing deconditioning closes the recovery cycle?

In some aging humans with postinfectious exertional intolerance, rebuilding may enable new pathogen production before injury and delayed loss despite early gains. Verified suppression without less new injury in an adequately sensitive window would constrain ongoing infection dependence, but not test rebuilding’s role

Explains the gap: Does rehabilitation that restores measured reserve nevertheless accelerate subsequent functional loss in aging humans with postinfectious exertional intolerance, contradicting the prediction that reversing deconditioning closes the recovery cycle?

In donor-matched older-human skin tissue–macrophage cultures, ingestion of recoverable cells may drive functional-cell loss. Failure to show ingestion-caused death, attachment-receptor dependence, dominance or net harm under adequate perturbation would constrain the corresponding claim.

Explains the gap: Which direct intervention—barrier lipid restoration, lysosomal membrane repair, or efferocytosis restoration—reduces human multitissue damage slopes beyond matched metabolic-demand reduction, and which rival-handle comparison reveals the responsible mechanism?

In a three-dimensional dermal system using older-human donor macrophages, mutual obstruction may limit dead-cell destruction and sustain injury. Failure of selective interference relief to restore clearance at relevant densities would challenge this mechanism in that regime.

Explains the gap: Which direct intervention—barrier lipid restoration, lysosomal membrane repair, or efferocytosis restoration—reduces human multitissue damage slopes beyond matched metabolic-demand reduction, and which rival-handle comparison reveals the responsible mechanism?

In older-human donor cells, initially proposed skin fibroblasts, altered protein chemistry may prevent breakdown despite restored processing. Comparable breakdown after ordinary processing is restored would weaken this claim; chemical correction must demonstrably enable destruction of the same protein backbone

Explains the gap: Which direct intervention—barrier lipid restoration, lysosomal membrane repair, or efferocytosis restoration—reduces human multitissue damage slopes beyond matched metabolic-demand reduction, and which rival-handle comparison reveals the responsible mechanism?

In paired older-human skin explants linked to human endothelial cells, a topical lipid may trigger a skin-made mediator that reduces remote damage. Selective mediator blockade must remove its protection and add-back restore it; failure would challenge this mechanism under adequately tested conditions.

Explains the gap: Which direct intervention—barrier lipid restoration, lysosomal membrane repair, or efferocytosis restoration—reduces human multitissue damage slopes beyond matched metabolic-demand reduction, and which rival-handle comparison reveals the responsible mechanism?

In aging human dermal fibroblast lineages, lysosomal waste export could restore lasting repair without sustained nuclear rejuvenation. Recovery with retained waste, safe export without recovery, or loss of recovery when younger nuclear changes are selectively reversed would challenge these claims.

Explains the gap: Does repeated partial reprogramming genuinely restore durable specialization within aging human lineages, or merely produce younger molecular averages by selecting survivors while losing regenerative diversity, growth control, or function after withdrawal?

In aging human dermal fibroblast lineages, partial reprogramming could restore durable specialization by repairing transcription-blocking lesions using an intact complementary strand. Preserved additional benefit under verified selective repair blockade would challenge this mechanism

Explains the gap: Does repeated partial reprogramming genuinely restore durable specialization within aging human lineages, or merely produce younger molecular averages by selecting survivors while losing regenerative diversity, growth control, or function after withdrawal?

Repeated partial reprogramming could leave inherited extra centrosomes in cycling aging human dermal fibroblasts, impairing repair after withdrawal despite initial recovery. Verified selective correction that leaves excess failure unchanged would challenge this mechanism

Explains the gap: Does repeated partial reprogramming genuinely restore durable specialization within aging human lineages, or merely produce younger molecular averages by selecting survivors while losing regenerative diversity, growth control, or function after withdrawal?

Partial reprogramming could alter the sugar-rich coat of aging human dermal fibroblasts, weakening attachment under repair load despite recovered nuclear identity. Correcting contact geometry without restoring attachment would challenge this mechanism

Explains the gap: Does repeated partial reprogramming genuinely restore durable specialization within aging human lineages, or merely produce younger molecular averages by selecting survivors while losing regenerative diversity, growth control, or function after withdrawal?

In older-human bronchial and immune-cell cultures from the same donor, synchronized removal could impair later recognition of damaged cells sharing the same antigens. Preserved surveillance after recovery would reject this link; faster endogenous accumulation requires separate demonstration

Explains the gap: In aging humans, must barrier repair precede selective damaged-cell removal and reserve loading; what functional recovery permits each next step, and does slower damage accumulation survive cessation or require maintenance?

In older-human alveolar repair cultures, cells may select the strongest effective pathway signal, delaying maturation while repair-initiation signaling dominates. Persistent response differences after a fixed pathway reset and equilibration would refute the proposed no-history rule

Explains the gap: In aging humans, must barrier repair precede selective damaged-cell removal and reserve loading; what functional recovery permits each next step, and does slower damage accumulation survive cessation or require maintenance?

In a specified older-human population, the combination could improve deficits while later damage accumulation remains equivalent to contemporaneous care. A reproducible exposure-linked rate difference beyond an independently justified margin would reject equivalence for that damage channel and interval.

Explains the gap: In aging humans, must barrier repair precede selective damaged-cell removal and reserve loading; what functional recovery permits each next step, and does slower damage accumulation survive cessation or require maintenance?

In older-human vascular smooth-muscle-cell cultures, remains from selective apoptotic removal could seed calcium-phosphate deposits under permissive chemistry. Unchanged total deposition after selective surface inactivation would challenge their proposed contribution

Explains the gap: In aging humans, must barrier repair precede selective damaged-cell removal and reserve loading; what functional recovery permits each next step, and does slower damage accumulation survive cessation or require maintenance?

In repaired older-human bronchial cultures, ordinary breathing-related deformation could injure genomes through nuclear-envelope rupture despite restored barrier function. Failure to establish rupture-mediated injury under validated ordinary loads would reject or leave this mechanism unresolved

Explains the gap: In aging humans, must barrier repair precede selective damaged-cell removal and reserve loading; what functional recovery permits each next step, and does slower damage accumulation survive cessation or require maintenance?

In a subset of aging humans, liver energy demand from recycling muscle lactate into glucose could sustain muscle activity after stress. Adequate tests showing no demand-driven return signal or only stable delayed recovery would reject the proposed self-maintaining loop in the tested setting.

Explains the gap: Does human aging amplify ordinary stress through reciprocal organ feedback, or do common inputs and unequal recovery delays create an apparent loop while each organ remains independently stable?

In older humans with limited kidney reserve, potassium may reduce kidney acid disposal, allowing retained acid to weaken muscle potassium uptake and reinforce the disturbance. Acid exposure reaching muscle only after its relevant response would reject the acute timing claim.

Explains the gap: Does human aging amplify ordinary stress through reciprocal organ feedback, or do common inputs and unequal recovery delays create an apparent loop while each organ remains independently stable?

In a subset of aging humans, impaired liver cortisol disposal could sustain a gut inflammatory signal that further impairs disposal. The proposed return pathway would be rejected in the tested setting if adequately represented, specifically perturbed pathways show no effect at physiological exposures.

Explains the gap: Does human aging amplify ordinary stress through reciprocal organ feedback, or do common inputs and unequal recovery delays create an apparent loop while each organ remains independently stable?

In a proposed older-adult human colonic epithelial mosaic with the donor's own immune cells, regeneration could delete protective T cells and leave a lasting surveillance deficit. Restored coverage despite deletion would refute that persistent-deficit link

Explains the gap: Does repeated regenerative stimulation accelerate human aging by selecting persistent high-fitness clones, even while average molecular damage falls, and can terminating the stimulus reverse that selection without sacrificing tissue renewal?

In older-adult human colonic epithelium, regenerative input could favor harmful lineages through overlapping failures of independently sufficient growth restraints. The mechanism is challenged if selectively changing joint escape leaves harmful divisions and retained output unchanged

Explains the gap: Does repeated regenerative stimulation accelerate human aging by selecting persistent high-fitness clones, even while average molecular damage falls, and can terminating the stimulus reverse that selection without sacrificing tissue renewal?

In aging human epithelial tissue already carrying replicating cancer-driving DNA outside chromosomes, repeated regeneration could favor higher-copy descendants and sustain excess growth after withdrawal; no preferential retained output would challenge selection, and validated output reduction tests growth dependence

Explains the gap: Does repeated regenerative stimulation accelerate human aging by selecting persistent high-fitness clones, even while average molecular damage falls, and can terminating the stimulus reverse that selection without sacrificing tissue renewal?

In older-adult human colonic epithelium, repeated alignment of regenerative pulses with responsive cell-cycle phases could favor harmful descendants. A recovery-only model that predicts schedule effects without repeated alignment would challenge this explanation within the experiment's resolution

Explains the gap: Does repeated regenerative stimulation accelerate human aging by selecting persistent high-fitness clones, even while average molecular damage falls, and can terminating the stimulus reverse that selection without sacrificing tissue renewal?

In prospectively specified cycling epithelial progenitors from aging humans, blocking interleukin-11 may increase structural repair errors despite reduced inflammatory injury and preserved early function. Bounded equivalence in repair accuracy for comparable initial lesions would constrain this claim

Explains the gap: Can IL-11 blockade fail to slow human aging despite suppressing its intended pathway, because impaired repair or host defense offsets reduced inflammation across tissues?

In older-human lung epithelial–stromal pairs, interleukin-11 signals may guide repair by reflecting a partner's state. Equivalent recovery with a state-independent schedule after accounting for receiver readiness, shared injury history and support would challenge the need for this guidance.

Explains the gap: Can IL-11 blockade fail to slow human aging despite suppressing its intended pathway, because impaired repair or host defense offsets reduced inflammation across tissues?

In ordinary human aging, blocking interleukin-11 could suppress its pathway without substantially slowing aging or causing consequential repair or infection costs. Meaningful benefit or harm beyond predefined equivalence bounds would reject neutrality within the tested tissue, exposure and duration.

Explains the gap: Can IL-11 blockade fail to slow human aging despite suppressing its intended pathway, because impaired repair or host defense offsets reduced inflammation across tissues?

In older-human epithelial cells, blocking interleukin-11 may release the shared receptor component gp130 to competing receptors and sustain harm. Testing must establish exchange within a limiting surface pool and sustained functional harm; neutral, beneficial or transient allocation would not confirm this harmful mechanism.

Explains the gap: Can IL-11 blockade fail to slow human aging despite suppressing its intended pathway, because impaired repair or host defense offsets reduced inflammation across tissues?

In susceptible aging-human epithelia, blocking interleukin-11 may alter protein processing and displayed self-peptide identities, allowing pre-existing memory T cells to cause persistent injury. Injury independent of the specified peptide-recognition interaction would argue against this mechanism.

Explains the gap: Can IL-11 blockade fail to slow human aging despite suppressing its intended pathway, because impaired repair or host defense offsets reduced inflammation across tissues?

In a prospectively characterized subgroup of older humans, maintained training could improve mobility while raising kidney filtration, sodium transport costs and lasting renal harm during ordinary warm activity. Precise absence of acquisition, excess oxygen cost, oxygen imbalance or sustained dysfunction would reject that link

Explains the gap: Can sustained training improve older humans' mobility while accelerating renal or intestinal reserve loss during ordinary heat and activity, falsifying the inference that greater muscle capacity necessarily lowers whole-body compensatory cost?

In a prospectively characterized subgroup of older humans, training could improve mobility while unequal adaptation of cardiovascular feedback causes recurrent kidney or intestinal blood-flow deficits. Precisely established absence of the acquired mismatch or tissue consequences would reject the corresponding link

Explains the gap: Can sustained training improve older humans' mobility while accelerating renal or intestinal reserve loss during ordinary heat and activity, falsifying the inference that greater muscle capacity necessarily lowers whole-body compensatory cost?

In older-human kidney or intestinal lining cells, protection may fade before heat-shock gene activation recovers, making repeated ordinary warm activity damaging despite mobility gains. Adequately resolved absence of this protection gap would reject the tested tissue-and-exposure version.

Explains the gap: Can sustained training improve older humans' mobility while accelerating renal or intestinal reserve loss during ordinary heat and activity, falsifying the inference that greater muscle capacity necessarily lowers whole-body compensatory cost?

In older humans, activity during maintained training could promote intestinal cell replacement; later gene reading during copying could cause inherited genome injury and impair renewal despite better mobility. No activity-induced replacement or consequential overlap would contradict the initiating mechanism

Explains the gap: Can sustained training improve older humans' mobility while accelerating renal or intestinal reserve loss during ordinary heat and activity, falsifying the inference that greater muscle capacity necessarily lowers whole-body compensatory cost?